Systemic lupus erythematosus (SLE) is characterized by the development of autoantibodies
associated with specific clinical manifestations. Previous studies have shown an association …

Objective Findings from cross‐sectional studies have revealed associations between DNA
methylation and systemic lupus erythematosus (SLE) outcomes. This study was undertaken …

Objectives Systemic lupus erythematosus (SLE) is a chronic autoimmune condition with
heterogeneous presentation and complex aetiology where DNA methylation changes are …

Systemic lupus erythematosus (SLE or lupus) is a heterogeneous autoimmune disease
characterized by the involvement of multiple organs and the production of antinuclear …

Objectives: To perform a cross-comparative analysis of DNA methylation in patients with
systemic lupus erythematosus (SLE), patients with primary Sjögren's syndrome (pSS), and …

Systemic lupus erythematosus (SLE) is an autoimmune disease with known genetic,
epigenetic, and environmental risk factors. To assess the role of DNA methylation in SLE, we …

Purpose of Review DNA methylation has emerged as an important contributing factor in the
pathogenesis of systemic lupus erythematosus (SLE). Here, we describe the DNA …

Patients with paediatric-onset systemic lupus erythematosus (SLE) often present with more
severe clinical courses than adult-onset patients. Although genome-wide DNA methylation …

Background Epigenetic variants have been shown in recent studies to be important
contributors to the pathogenesis of systemic lupus erythematosus (SLE). Here, we report a 2 …

Systemic lupus erythematosus is a chronic-relapsing autoimmune disease of incompletely
understood etiology. Recent evidence strongly supports an epigenetic contribution to the …